FDA Approves First At-Home Test For COVID And Flu

Via press release from the FDA:

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first over-the-counter (OTC) at-home diagnostic test that can differentiate and detect influenza A and B, commonly known as the flu, and SARS-CoV-2, the virus that causes COVID-19. The Lucira COVID-19 & Flu Home Test is a single-use at-home test kit that provides results from self-collected nasal swab samples in roughly 30 minutes.

The Lucira COVID-19 & Flu Home Test is a single use test for individuals with signs and symptoms consistent with a respiratory tract infection, including COVID-19. The test can be purchased without a prescription and performed completely at-home using nasal swab samples self-collected by individuals ages 14 years or older or collected by an adult for individuals 2 years of age or older.

Today we issued an emergency use authorization for the first over-the-counter at-home diagnostic test that can detect both the flu and #COVID19. The test provides results from self-collected nasal swab samples in roughly 30 minutes.

Learn more ➡️https://t.co/LVJLsWxQVk pic.twitter.com/S2RsJb0TNv

— U.S. FDA (@US_FDA) February 24, 2023